Lyell Wealth Management, LP Dexcom Inc Transaction History

Lyell Wealth Management, LP

$1.09 Billion
Q3 2024

A detailed history of Lyell Wealth Management, LP transactions in Dexcom Inc stock. As of the latest transaction made, Lyell Wealth Management, LP holds 65,040 shares of DXCM stock, worth $4.96 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

65,040

Previous 64,915 0.19%

Holding current value

$4.96 Million

Previous $7.36 Million 40.79%

% of portfolio

0.4%

Previous 0.7%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$64.0 - $116.06 $8,000 - $14,507	125 Added 0.19%	65,040 $4.36 Million
Q2 2024 Aug 08, 2024	SELL	$110.31 - $140.45 $346,924 - $441,715	-3,145 Reduced 4.62%	64,915 $7.36 Million
Q1 2024 May 03, 2024	SELL	$114.22 - $140.1 $253,796 - $311,302	-2,222 Reduced 3.16%	68,060 $9.44 Million
Q4 2023 Feb 02, 2024	SELL	$75.49 - $124.16 $1.13 Million - $1.86 Million	-14,981 Reduced 17.57%	70,282 $8.72 Million
Q3 2023 Oct 31, 2023	SELL	$86.06 - $137.93 $580,560 - $930,475	-6,746 Reduced 7.33%	85,263 $7.96 Million
Q2 2023 Aug 04, 2023	SELL	$112.47 - $130.98 $207,057 - $241,134	-1,841 Reduced 1.96%	92,009 $11.8 Million
Q1 2023 May 03, 2023	SELL	$104.0 - $122.92 $678,392 - $801,807	-6,523 Reduced 6.5%	93,850 $10.9 Million
Q4 2022 Jan 24, 2023	SELL	$84.98 - $122.67 $513,874 - $741,785	-6,047 Reduced 5.68%	100,373 $0
Q3 2022 Oct 24, 2022	SELL	$76.35 - $94.18 $182,094 - $224,619	-2,385 Reduced 2.19%	106,420 $8.57 Million
Q2 2022 Jul 28, 2022	BUY	$67.99 - $132.89 $5.51 Million - $10.8 Million	80,973 Added 290.93%	108,805 $8.11 Million
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $4,327 - $5,989	-46 Reduced 0.17%	27,832 $14.2 Million
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $66,623 - $83,526	513 Added 1.87%	27,878 $15 Million
Q3 2021 Nov 10, 2021	BUY	$106.71 - $143.18 $34,253 - $45,960	321 Added 1.19%	27,365 $15 Million
Q2 2021 Aug 09, 2021	SELL	$80.99 - $107.93 $36,040 - $48,028	-445 Reduced 1.62%	27,044 $11.5 Million
Q1 2021 May 07, 2021	BUY	$84.79 - $104.74 $57,318 - $70,804	676 Added 2.52%	27,489 $9.88 Million
Q4 2020 Feb 04, 2021	BUY	$78.0 - $104.5 $83,226 - $111,501	1,067 Added 4.14%	26,813 $9.91 Million
Q3 2020 Nov 04, 2020	BUY	$95.51 - $112.95 $17,287 - $20,443	181 Added 0.71%	25,746 $10.6 Million
Q2 2020 Jul 30, 2020	BUY	$62.68 - $105.34 $37,419 - $62,887	597 Added 2.39%	25,565 $10.4 Million
Q1 2020 May 11, 2020	BUY	$47.79 - $75.63 $44,157 - $69,882	924 Added 3.84%	24,968 $6.72 Million
Q4 2019 Feb 05, 2020	BUY	$36.62 - $57.29 $144,502 - $226,066	3,946 Added 19.63%	24,044 $5.26 Million
Q3 2019 Nov 06, 2019	BUY	$35.53 - $43.8 $714,081 - $880,292	20,098 New	20,098 $3 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lyell Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lyell Wealth Management, LP with notifications on news.

Account

Lyell Wealth Management, LP Dexcom Inc Transaction History